Recursion Pharmaceuticals (NasdaqGS:RXRX) reported a 10% decline in its share price last week as it announced first-quarter 2025 results with an increased net loss despite rising sales and revenue.

ChatGPT and GPT-4 Turbo, two cutting-edge Artificial Intelligence tools developed by OpenAI, are redefining the landscape of programming in 2025. These AI models empower developers-from beginners to ...

Master data science in 2025. Complete guide to machine learning, big data analytics, Python programming, statistical modeling ...